Evidence map›Paper›PMID 22535253›Full record

ArticleAge (Dordrecht, Netherlands)2013

Variations in the protein level of Omi/HtrA2 in the heart of aged rats may contribute to the increased susceptibility of cardiomyocytes to ischemia/reperfusion injury and cell death : Omi/HtrA2 and aged heart injury.

Ke Wang, Jie Zhang, Jingyi Liu, Jue Tian, Ye Wu, Xiaoliang Wang, Lin Quan, Haibo Xu, Wen Wang, Huirong Liu

Open access · bronzeAbstract read
In one paragraph

Article in Age (Dordrecht, Netherlands), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 40 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Ischemia/Reperfusion.Comprehensive Physiology · 2016
    Review
  12. Mitochondrial Metabolism in Aging Heart.Circulation research · 2016
    Review
  13. Cloning and Transcriptional Activity of the Mouse Omi/HtrA2 Gene Promoter.International journal of molecular sciences · 2016
    Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Ke WangDepartment of Pathophysiology, School of Basic Medical Sciences, Capital Medical University, 10 Xitoutiao, You An Men, P.O. Box 907, Beijing, 100069, People's Republic of China.
Jie Zhang
Jingyi Liu
Jue Tian
Ye Wu
Xiaoliang Wang
Lin Quan
Haibo Xu
Wen Wang
Huirong Liu
Capital Medical University · CNShanxi Medical University · CNBeijing YouAn Hospital · CNNingxia Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Survival after acute myocardial infarction is decreased in elderly patients. The enhanced rates of apoptosis in the aging heart exacerbate myocardial ischemia/reperfusion (MI/R) injury. We have recently demonstrated that the X-linked inhibitor of apoptosis protein (XIAP), the most potent endogenous inhibitor of apoptosis, was decreased in aging rats' hearts. XIAP was balanced by two mitochondria proteins, Omi/HtrA2 and Smac/DIABLO. However, the implicative role of XIAP, Omi/HtrA2, and Smac/DIABLO to aging-related MI/R injury has not been previously investigated. In our study, male aging rats (20-24 months) or young adult rats (4-6 months) were subjected to 30 min of myocardial ischemia followed by reperfusion. MI/R-induced cardiac injury was enhanced in aging rats, as evidenced by aggravated cardiac dysfunction, enlarged infarct size, and increased myocardial apoptosis (TUNEL and caspase-3 activity). Then, the XIAP, Omi/HtrA2, and Smac/DIABLO protein and mRNA expression was detected. XIAP protein and mRNA expression was decreased in both aging hearts and aging hearts subjected to MI/R. Meanwhile, myocardial XIAP protein expression was correlated to cardiac function after MI/R. However, Omi/HtrA2, but not Smac/DIABLO, expression was increased in aging hearts. Moreover, the translocation of Omi/HtrA2 from mitochondria to cytosol was increased in both aging hearts and aging hearts subjected to MI/R. Treatment with ucf-101 (a novel and specific Omi/HtrA2 inhibitor) attenuated XIAP degradation and caspase-3 activity and exerted cardioprotective effects. Taken together, these results demonstrated that increased expression and leakage of Omi/HtrA2 enhanced MI/R injury in aging hearts via degrading XIAP and promoting myocardial apoptosis.

Indexed as

Gene Expression RegulationAgingAnimalsApoptosis Regulatory ProteinsBlotting, WesternCarrier ProteinsCell DeathDisease Models, AnimalHigh-Temperature Requirement A Serine Peptidase 2In Situ Nick-End LabelingMaleMitochondria, HeartMitochondrial ProteinsMyocardial Reperfusion InjuryMyocytes, CardiacNerve Tissue ProteinsApoptosis Regulatory ProteinsCarrier ProteinsDIABLO protein, ratHigh-Temperature Requirement A Serine Peptidase 2Mitochondrial ProteinsNerve Tissue ProteinsRNA-Binding ProteinsRNA, MessengerSerine-Arginine Splicing FactorsSerine EndopeptidasesTra2b protein, ratX-Linked Inhibitor of Apoptosis Protein

Identifiers

PMID22535253
PMCPMC3636415
OpenAlexW1985015625

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.